Clinical Overview

“Early Repolarization Of The Ventricles” (ERV) is this dataset’s label for the electrocardiographic finding more commonly called the early repolarization pattern (ERP) — J-point elevation with QRS notching or slurring, most often in the inferior and/or lateral leads. Unlike some of this dataset’s other ST/T-segment labels, this one maps precisely: a direct lookup against the HL7 FHIR terminology server (SNOMED CT International edition, release 20250201) resolves ERV’s dataset code to the concept “Early repolarization (finding)” — confirmed independently against a second terminology server (SNOMED CT Australian edition, release 20260731) — so the dataset’s acronym and the standard clinical concept are the same thing, not a generic or mismatched umbrella tag. The reference ECG definition (Macfarlane et al.’s 2015 international consensus paper, still cited as the field’s criteria by a 2023 emergency-medicine review of this pattern) requires three elements together: an end-QRS notch or slur on the downslope of a prominent R wave, positioned above the baseline; J-point amplitude of at least 0.1 mV in two or more consecutive leads, excluding V1-V3; and a QRS duration under 120 ms. Most tracings also show a normal or rapidly upsloping ST segment and tall, slightly asymmetric T waves concordant with the QRS, though ST-segment behavior is not itself part of the diagnostic definition.

Two related terms are worth keeping separate. “Early repolarization pattern” (ERP) is the isolated ECG appearance described above, which — as detailed below — is overwhelmingly a benign variant. “Early repolarization syndrome” (ERS) is reserved for the much smaller group of patients in whom this same ECG pattern is found alongside a survived episode of idiopathic ventricular fibrillation or unexplained sudden cardiac arrest, or a strong family history of sudden death; the Merck Manual frames ERS specifically as a channelopathy — an inherited cardiomyocyte ion-channel disorder — rather than simply “early repolarization with bad luck.” This page describes the ECG pattern; the real-record set behind it should not be read as a diagnosis of the syndrome.

The proposed mechanism centers on a transmural (epicardial-to-endocardial) voltage gradient during phase 1 of the ventricular action potential. A relatively prominent transient outward potassium current (Ito) — alongside, in some proposed models, decreased inward sodium or calcium current — produces a deeper action-potential notch in epicardial cells than in endocardial cells, and that mismatch is what the surface ECG registers as J-point elevation and QRS notching or slurring. In the higher-risk (“malignant”) morphology, further accentuation of this gradient can disproportionately shorten the epicardial action potential relative to the endocardium, creating a substrate for phase 2 reentry — closely coupled premature ventricular extrasystoles arising from the voltage mismatch that can trigger polymorphic ventricular tachycardia or fibrillation. This is a cellular mechanism inferred from experimental and modeling studies rather than something observed directly at the bedside, and how it maps onto risk in an individual patient remains an active research question.

In isolation, this pattern is very common and, for the large majority of people who have it, entirely benign: population studies put its prevalence at roughly 3-15% of adults depending on the diagnostic criteria and population studied, rising to a pooled mean of 31.6% across a 2024 systematic review of over 44,000 athletes, where it was more common in men and in Black athletes than in other groups — and where multi-year follow-up (3 to 24 years across the pooled studies) recorded no sudden cardiac deaths or major cardiovascular events attributable to an isolated pattern. Set against that reassuring picture, the largest published meta-analysis on the question (Cheng et al., 2016, pooling 16 studies and 334,524 subjects) found that people with this pattern carried a significantly higher relative risk of sudden cardiac arrest (RR 2.18), cardiac death (RR 1.48), and death from any cause (RR 1.21) than people without it, translating to an estimated 139.6 additional sudden cardiac arrests and 227.6 additional cardiac deaths per 100,000 person-years. That same meta-analysis is also the source of this pattern’s risk stratification: J-point elevation of at least 0.2 mV in the inferior leads specifically (RR 2.92 for sudden cardiac arrest, RR 2.98 for cardiac death), a notching rather than slurring configuration, and a horizontal or descending ST segment (RR 6.93 for cardiac death, versus no significant excess risk from a rapidly ascending ST segment) each independently marked a higher-risk subgroup — the same “malignant” features named in more recent reviews. [CLINICAL REVIEW NEEDED]: that meta-analysis also found the excess mortality risk was statistically significant in Asian and white populations but not in African American subjects, despite Black individuals showing the highest population prevalence of the pattern in several other cited sources; the study authors could not explain the discrepancy, and this page does not attempt to resolve it — treat any race-based risk stratification with caution pending further study.

An isolated benign pattern causes no symptoms of its own — it is found incidentally on a routine or otherwise-unrelated tracing. When symptoms are present, they belong to the associated syndrome (ERS) rather than to the pattern itself: palpitations, or, more often, the pattern is first discovered only after a resuscitated cardiac arrest, since the polymorphic ventricular arrhythmia it can trigger rarely self-terminates the way a milder tachyarrhythmia might. That rare self-termination is also why syncope — a “warning” a patient might survive to report — is comparatively uncommon in this condition relative to other arrhythmic syndromes.

This pattern is most prevalent in young (particularly under 50), male, athletic, and Black individuals, and its prevalence declines with age — it is reported as rare after 70. Features that should raise concern for the higher-risk phenotype, beyond the ECG morphology itself, include a personal history of unexplained syncope or resuscitated cardiac arrest, a family history of sudden unexplained death at a young age, and coexisting structural heart disease. Clinicians are cautioned against diagnosing this pattern as a benign variant in patients over 50, particularly those with risk factors for ischemic heart disease, since the same J-point elevation appearance can also be produced by causes that are not benign at all — see Differential Diagnosis below.

Interpretation Guide

Key Features:

• Rate: not defining — this pattern can accompany any heart rate, though the J-wave amplitude itself tends to increase during slower heart rates and after a “short-long-short” beat sequence, and is attenuated by sympathetic stimulation (the physiologic basis for the isoproterenol-based treatment described in Treatment Brief below)
• Rhythm: not defining — this finding is a QRS/ST-segment morphology superimposed on the underlying rhythm, not the rhythm itself
• P waves: within normal limits for the underlying rhythm; not part of this finding
• PR interval: within normal limits for the underlying rhythm; not part of this finding
• QRS complex: normal duration (under 120 ms is part of the diagnostic definition itself); the defining feature is a notch or slur on the downslope of a prominent R wave, positioned above the baseline, at the QRS-ST junction (the J point)
• ST segment: typically normal or rapidly (“rapidly ascending”) upsloping immediately after the J-point elevation in the benign form; a horizontal or descending ST segment immediately after the J point is the single ST-segment feature most strongly associated with the higher-risk phenotype, and should not be assumed present just because this label is applied
• T waves: often tall and mildly asymmetric, concordant with (pointing the same direction as) the QRS complex, particularly in the precordial leads; a normal-appearing T wave does not by itself rule the higher-risk phenotype in or out
• QT interval: not defining, and generally normal; a genuinely prolonged QT in the presence of J-point elevation should prompt consideration of a distinct repolarization abnormality rather than being attributed to this pattern
• Other findings: J-point amplitude of 0.2 mV (about 2 mm) or more, a notching rather than slurring terminal-QRS deflection, and involvement of the inferior leads specifically are the three individual features most consistently associated with higher arrhythmic risk in the largest published outcome meta-analysis; compare against a prior ECG whenever one is available, since an appearance that is stable and unchanged over time is itself one of the recognized reassuring features

Key Leads

• II, III, aVF (inferior leads) — the location most consistently associated with higher arrhythmic risk in outcome studies; J-point elevation confined to these leads (or spanning both the inferior and lateral leads together) carried a significantly elevated relative risk for sudden cardiac arrest in the largest published meta-analysis, unlike lateral-only involvement
• I, aVL, V4-V6 (lateral leads) — the other lead group included in the diagnostic definition; lateral-only J-point elevation was associated with a modest increase in all-cause mortality risk in outcome data but, unlike inferior involvement, was not independently associated with sudden-cardiac-arrest risk
• V2-V5 — the classic distribution for the typical, usually benign “fish-hook” appearance most often described in young and athletic patients, with widespread, concave ST elevation
• V6 — a useful bedside discriminator against pericarditis: an ST-elevation-to-T-wave-amplitude ratio under 0.25 in this lead favors this benign pattern, while a ratio above that threshold favors pericarditis instead

Not lead-agnostic: risk and morphology both depend materially on which leads show the finding, so a full 12-lead assessment — not just the lead where it is first noticed — is required.

Differential Diagnosis

• ST Tilt Up (STTU) — this dataset’s other, less specific “ST is elevated” label; unlike this pattern, it carries no requirement for the specific terminal-QRS notch/slur criteria, so a record tagged STTU is not necessarily showing this pattern’s defining J-point morphology at all.
• Myocardial Infarction In The Side Wall (MISW) — the differential with the highest stakes: acute ST-elevation myocardial infarction can mimic this pattern’s J-point elevation, but favors convex (“tombstone”) rather than concave ST morphology, reciprocal ST depression in other leads, an evolving (not static) appearance across serial tracings, and a rise in cardiac biomarkers — none of which are features of this benign pattern.
• Left Ventricle Hypertrophy (LVH) — LVH’s strain pattern produces ST-segment changes from voltage overload rather than the phase-1 repolarization gradient described above, and characteristically shows ST depression with asymmetric T-wave inversion in the lateral leads — the opposite direction from this pattern’s typical ST-segment behavior — alongside voltage criteria for hypertrophy.
• ST-T Change (STTC) — this dataset’s label for a combined ST-and-T-wave abnormality; this pattern’s defining feature is specifically the terminal-QRS notch/slur at the J point, and its T waves, when notable at all, are usually just tall and concordant rather than showing the more overt abnormality STTC implies.
• Abnormal Q Wave (AQW) — pathologic Q waves reflect myocardial necrosis and generally persist on serial tracings once established, unlike this pattern’s static, non-progressive J-point notching, which is not itself evidence of any prior infarction.

Treatment Brief

This pattern is a finding to characterize, not by itself a target for treatment — the great majority of the time, once the higher-risk features below are excluded, no intervention is needed at all.

• Compare against a prior ECG whenever one is available: a J-point/ST-segment appearance that is unchanged over time is itself one of the recognized reassuring (benign) features, while a new or dynamic change is not.
• Check for the higher-risk ECG features specifically — J-point elevation of 0.2 mV (about 2 mm) or more, a notching rather than slurring terminal-QRS deflection, a horizontal or descending (rather than rapidly ascending) ST segment immediately after the J point, and involvement of the inferior leads — since these carry materially more weight in outcome data than the presence of the pattern alone.
• Ask about a personal history of unexplained syncope or a prior resuscitated cardiac arrest, and a family history of sudden unexplained death at a young age; either raises concern for the higher-risk “early repolarization syndrome” phenotype rather than a benign isolated pattern and warrants provider notification and specialist (electrophysiology) referral.
• Do not treat this as a benign variant in a patient over 50, especially one with risk factors for ischemic heart disease, without first excluding the differentials above — obtain serial ECGs and cardiac biomarkers, and avoid reflexive thrombolytic administration on the strength of ST elevation alone; this pattern has a documented history of being overcalled as myocardial infarction in the emergency setting.
• Echocardiography to assess for structural heart disease or a regional wall-motion abnormality is a reasonable next step when the picture is ambiguous; escalation to cardiac catheterization is reserved for genuinely high-risk presentations — new ischemic symptoms plus biomarker elevation — rather than the ECG finding by itself.
• For patients who have already survived a cardiac arrest with this pattern (confirmed early repolarization syndrome), definitive management is implantable cardioverter-defibrillator placement; recurrent arrhythmic episodes in that population may be treated with quinidine or IV isoproterenol under specialist care, targeting the same repolarization gradient described in Clinical Overview above.